Cognitive Control to Boost Physical Activity Adherence
ConditionPhysical Inactivity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorUniversity of Iowa
About this trial
This trial is designed to develop and test the efficacy of cognitive training strategies to improve self-regulatory capacities for middle-aged adults to adopt and sustain a physically active lifestyle. The main questions it aims to answer are:
* Can cognitive training designed to improve cognitive control improve physical activity adherence? * What are the psychological, physiological, cognitive, and sociodemographic factors that affect the impact of cognitive control on physical activity adherence?
Participants will
* Complete a 6-week home-based, computerized cognitive training program * Complete a 6-week home-based, aerobic exercise training program with supervision of a health coach and trainer * Complete a 6-week home-based, aerobic exercise training program prescribed by a health coach and trainer * Visit the laboratory before and after cognitive training, and before and after physical training, to complete assessments of cognition and aerobic fitness
Eligibility criteria
Qualifiers
Between the ages of 40 and 65 years old
Full-time working status of an average of 35 hrs./week or more
Scoring as "Low Active" by the short form of the International Physical Activity Questionnaire (IPAQ)
Eligible to participate in an aerobic exercise intervention based on the Physical Activity Readiness Questionnaire
Disqualifiers
Impairments in hearing inhibiting the ability to discuss study instructions or directions
Visual impairments that prevent the perception of color, or loss of sight in the visual field
Qualify as "high risk" for exercise-induced adverse events by American College of Sports Medicine criteria will be excluded, which includes known or symptomatic chronic cardiovascular or metabolic disease
Not fluent in English
Trial design
Treatments tested in this trial
- Cognitive training
- Exercise
Treatment groups
264 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Iowa
Lead sponsor
Northeastern University
Collaborator
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov